Clinical Trial Update: SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving Methotrexate [Phase 2]

View source ↗

Summary

Phase 2 trial of SCIO-469 in rheumatoid arthritis patients not receiving methotrexate has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• SCIO-469

Snippet

Sponsor: Scios, Inc. | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED